Biokinetic and PBPK Modelling to Support Read-Across Assessment of Repeat Dose and Developmental and Reproductive Toxicity of Valproic Acid Analogues Poster Biokinetic and PBPK Modelling to Support Read-Across Assessment of Repeat Dose and Developmental and Reproductive Toxicity of Valproic Acid Analogues Danielle Pillsbury2019 年 9 月 4 日
Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human Poster Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human Danielle Pillsbury2019 年 9 月 4 日
Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations Poster Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations Danielle Pillsbury2019 年 9 月 3 日
Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. 海报 Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. Danielle Pillsbury2019 年 9 月 3 日
Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Poster Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Danielle Pillsbury2019 年 9 月 3 日
Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Poster Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Danielle Pillsbury2019 年 9 月 3 日
Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Poster Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Danielle Pillsbury2019 年 9 月 3 日
Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Poster Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Danielle Pillsbury2019 年 9 月 3 日
Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Poster Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Danielle Pillsbury2019 年 9 月 3 日
Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Poster Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Danielle Pillsbury2019 年 9 月 3 日
